Philadelphia biotech leaders want to rethink the industry’s investment playbook
Dean Jonathan Epstein of the Perelman School of Medicine explains why the drug development funding playbook that worked for decades is now in trouble.
Dean Jonathan Epstein of the Perelman School of Medicine explains why the drug development funding playbook that worked for decades is now in trouble.
Mohamed El-Erian of the Wharton School writes that the issue of affordability contributes to economic instability, social fracture, and political polarization.
The Journal reviews “Having It All,” the new book by Corrine Low of the Wharton School.
Sanya Carley of the Kleinman Center for Energy Policy at the Weitzman School of Design says that 1 in 4 American households struggle to pay their energy bills and keep their homes at livable temperatures.
Benjamin Lee of the School of Engineering and Applied Science says deployment of AI technologies is driving up energy costs.
Kiran Musunuru of the Perelman School of Medicine comments on CRISPR gene-editing as a way to reduce cholesterol.
Architect Peter-Ayers Tarantino, a Penn grad, is profiled for his extensive collection of books.
Daniel Soffer of the Perelman School of Medicine comments on healthy cholesterol levels.
Karen B. Lasater of the School of Nursing says attention to nursing-staffing standards is important to hospital accreditation.
Paul Nary of the Wharton School weighs in on why owners of Kimberly-Clark may be OK with the risk ion creating an opportunity to make more money.